English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/76397
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Altered transcriptional regulators in response to serum in immortalized lympozytes from Alzheimer disease patients

AuthorsDe las Cuevas, Natividad; Muñoz, Úrsula CSIC; García-Hermida, Ofelia; Martín-Requero, Ángeles CSIC ORCID
KeywordsAlzheimer's disease
Issue Date2005
CitationNeurobiology of Aging, 26: 615-624 (2005)
AbstractCell cycle disturbances may precede neuronal death in Alzheimer's disease (AD). We described alterations, in lymphocytes from AD patients, on the activity of two transcription factors, E2F and NF-κB, involved in cell proliferation and survival regulation, demonstrating that cell cycle dysfunction also occurs in peripheral cells. The analysis of E2F–DNA binding activity revealed lower signal intensity of protein–DNA complexes in AD cells, which correlated with increased phosphorylation of retinoblastoma (pRb) related proteins and enhanced proliferation. The calmodulin (CaM) antagonist calmidazolium (CMZ) abrogated the increased activity of AD cells by partially dephosphorylating pRb and p130. The NF-κB–DNA binding activity increased as cell progress through the cell cycle. The reduced NF-κB activation observed in AD cells appears not to be related to the increased phosphorylation of the pRb family proteins nor with the enhanced proliferative activity of AD cells, but seems to protect them from death induced by the loss of trophic support. Ca2+/CaM antagonists rescue NF-κB–DNA binding activity and sensitize AD cells to serum withdrawal. These observations suggest that disruption of Ca2+/CaM signaling pathway could be linked mechanistically to its pro cell survival actions, promoting enhanced proliferation or decreased cell death depending on the presence of growth-stimulatory signals
DescriptionThis work has been supported by grants from the Spanish Fondo de Investigaciones Sanitarias (01/1194), Ministerio de Ciencia y Tecnología (SAF 2003-01458) and the “Fundación Rodríguez Pascual”. N.C. and U.M. are fellows from the Fondo de Investigaciones Sanitarias de la Seguridad Social and Ministerio de Educación y Cultura, respectively
Publisher version (URL)http://dx.doi.org/10.1016/j.neurobiolaging.2004.06.006
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.